Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Other financing activities (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Other financing activities for 15 consecutive years, with $19000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other financing activities fell 97.75% year-over-year to $19000.0, compared with a TTM value of $531000.0 through Dec 2025, down 85.37%, and an annual FY2025 reading of $531000.0, down 85.37% over the prior year.
  • Other financing activities was $19000.0 for Q2 2025 at Orthofix Medical, down from $512000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.9 million in Q4 2021 and bottomed at -$385000.0 in Q1 2021.
  • Average Other financing activities over 5 years is $454875.0, with a median of $192500.0 recorded in 2022.
  • The sharpest move saw Other financing activities soared 1921.74% in 2023, then plummeted 97.75% in 2025.
  • Year by year, Other financing activities stood at $1.9 million in 2021, then tumbled by 91.47% to $160000.0 in 2022, then skyrocketed by 936.25% to $1.7 million in 2023, then plummeted by 38.9% to $1.0 million in 2024, then tumbled by 98.12% to $19000.0 in 2025.
  • Business Quant data shows Other financing activities for OFIX at $19000.0 in Q2 2025, $512000.0 in Q1 2025, and $1.0 million in Q4 2024.